Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Safety and Feasibility of Metformin Treatment in Infants After Perinatal Brain Injury

NCT05590676 is registered in ClinicalTrials.gov with The Hospital for Sick Children as lead sponsor.

NCT NCT05590676
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05590676 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Safety and Feasibility of Metformin Treatment in Infants After Perinatal Brain Injury
Lead sponsor
The Hospital for Sick Children
Phase
Phase 1
Overall status
Terminated
Start date
May 2, 2023
Completion date
February 22, 2024
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypoxic ischemic encephalopathy of newborn, premature birth